Matrix Metalloproteinase 13

"Matrix Metalloproteinase 13" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A secreted matrix metalloproteinase that plays a physiological role in the degradation of extracellular matrix found in skeletal tissues. It is synthesized as an inactive precursor that is activated by the proteolytic cleavage of its N-terminal propeptide.

Descriptor ID	D053509
MeSH Number(s)	D08.811.277.656.300.480.205.363 D08.811.277.656.300.480.525.700.550 D08.811.277.656.675.374.205.363 D08.811.277.656.675.374.525.700.550 D12.644.276.848.550 D12.776.467.836.550
Concept/Terms	Matrix Metalloproteinase 13 Matrix Metalloproteinase 13 Metalloproteinase 13, Matrix Matrix Metalloproteinase-13 Metalloproteinase-13, Matrix MMP13 Metalloproteinase Metalloproteinase, MMP13 MMP-13 Metalloproteinase MMP 13 Metalloproteinase Metalloproteinase, MMP-13 Collagenase-3 Collagenase 3

Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 13".

Chemicals and Drugs [D]
Enzymes and Coenzymes [D08]
Enzymes [D08.811]
Hydrolases [D08.811.277]
Peptide Hydrolases [D08.811.277.656]
Endopeptidases [D08.811.277.656.300]
Metalloendopeptidases [D08.811.277.656.300.480]
Collagenases [D08.811.277.656.300.480.205]
Matrix Metalloproteinase 13 [D08.811.277.656.300.480.205.363]
Matrix Metalloproteinases [D08.811.277.656.300.480.525]
Matrix Metalloproteinases, Secreted [D08.811.277.656.300.480.525.700]
Matrix Metalloproteinase 13 [D08.811.277.656.300.480.525.700.550]
Metalloproteases [D08.811.277.656.675]
Metalloendopeptidases [D08.811.277.656.675.374]
Collagenases [D08.811.277.656.675.374.205]
Matrix Metalloproteinase 13 [D08.811.277.656.675.374.205.363]
Matrix Metalloproteinases [D08.811.277.656.675.374.525]
Matrix Metalloproteinases, Secreted [D08.811.277.656.675.374.525.700]
Matrix Metalloproteinase 13 [D08.811.277.656.675.374.525.700.550]
Amino Acids, Peptides, and Proteins [D12]
Peptides [D12.644]
Intercellular Signaling Peptides and Proteins [D12.644.276]
Matrix Metalloproteinases, Secreted [D12.644.276.848]
Matrix Metalloproteinase 13 [D12.644.276.848.550]
Proteins [D12.776]
Intercellular Signaling Peptides and Proteins [D12.776.467]
Matrix Metalloproteinases, Secreted [D12.776.467.836]
Matrix Metalloproteinase 13 [D12.776.467.836.550]

Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 13".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Matrix Metalloproteinase 13" by people in this website by year, and whether "Matrix Metalloproteinase 13" was a major or minor topic of these publications.

Bar chart showing 3 publications over 3 distinct years, with a maximum of 1 publications in 2005 and 2007 and 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	0	1	1
2007	0	1	1
2018	1	0	1

Below are the most recent publications written about "Matrix Metalloproteinase 13" by people in Profiles.

Rana R, Huang T, Koukos G, Fletcher EK, Turner SE, Shearer A, Gurbel PA, Rade JJ, Kimmelstiel CD, Bliden KP, Covic L, Kuliopulos A. Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2018 06; 38(6):1368-1380.

View in: PubMed
Kc R, Li X, Voigt RM, Ellman MB, Summa KC, Vitaterna MH, Keshavarizian A, Turek FW, Meng QJ, Stein GS, van Wijnen AJ, Chen D, Forsyth CB, Im HJ. Environmental disruption of circadian rhythm predisposes mice to osteoarthritis-like changes in knee joint. J Cell Physiol. 2015 Sep; 230(9):2174-2183.

View in: PubMed
Salaün M, Peng J, Hensley HH, Roder N, Flieder DB, Houlle-Crépin S, Abramovici-Roels O, Sabourin JC, Thiberville L, Clapper ML. MMP-13 In-Vivo Molecular Imaging Reveals Early Expression in Lung Adenocarcinoma. PLoS One. 2015; 10(7):e0132960.

View in: PubMed
Fitzgerald JB, Jin M, Chai DH, Siparsky P, Fanning P, Grodzinsky AJ. Shear- and compression-induced chondrocyte transcription requires MAPK activation in cartilage explants. J Biol Chem. 2008 Mar 14; 283(11):6735-43.

View in: PubMed
Taylor KR, Yamasaki K, Radek KA, Nardo AD, Goodarzi H, Golenbock D, Beutler B, Gallo RL. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem. 2007 Jun 22; 282(25):18265-18275.

View in: PubMed
Ijiri K, Zerbini LF, Peng H, Correa RG, Lu B, Walsh N, Zhao Y, Taniguchi N, Huang XL, Otu H, Wang H, Wang JF, Komiya S, Ducy P, Rahman MU, Flavell RA, Gravallese EM, Oettgen P, Libermann TA, Goldring MB. A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J Biol Chem. 2005 Nov 18; 280(46):38544-55.

View in: PubMed
Javed A, Barnes GL, Pratap J, Antkowiak T, Gerstenfeld LC, van Wijnen AJ, Stein JL, Lian JB, Stein GS. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc Natl Acad Sci U S A. 2005 Feb 01; 102(5):1454-9.

View in: PubMed
Li TF, Zuscik MJ, Ionescu AM, Zhang X, Rosier RN, Schwarz EM, Drissi H, O'Keefe RJ. PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling. Exp Cell Res. 2004 Oct 15; 300(1):159-69.

View in: PubMed

People

Explore

Similar Concepts

Top Journals